BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 17690412)

  • 1. Seroprevalence of antibodies to parvovirus B19 among children in Papua New Guinea.
    Wildig J; Mueller I; Kiniboro B; Maraga S; Siba P; Cossart Y
    Am J Trop Med Hyg; 2007 Aug; 77(2):354-7. PubMed ID: 17690412
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Parvovirus B19 infection contributes to severe anemia in young children in Papua New Guinea.
    Wildig J; Michon P; Siba P; Mellombo M; Ura A; Mueller I; Cossart Y
    J Infect Dis; 2006 Jul; 194(2):146-53. PubMed ID: 16779719
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Investigation of parvovirus B19 seroprevalence in various age groups in Central Anatolia Region, Turkey].
    Türk Dağı H; Ozdemir M; Baykan M; Baysal B
    Mikrobiyol Bul; 2010 Jul; 44(3):467-72. PubMed ID: 21063997
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Seroprevalence of parvovirus B19 IgG in children affected by juvenile idiopathic arthritis.
    Weissbrich B; Süss-Fröhlich Y; Girschick HJ
    Arthritis Res Ther; 2007; 9(4):R82. PubMed ID: 17760961
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Seroprevalence of human parvovirus B 19 antibodies (Sticker's disease/erythema infectiosum) in the DRG population].
    Wiersbitzky S; Schwarz TF; Bruns R; Jäger G; Bittner S; Weidemann H; Deinhardt F; Hottenträger B; Abel E; Ladstätter L
    Kinderarztl Prax; 1990 Apr; 58(4):185-9. PubMed ID: 2164118
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of transfusion on human erythrovirus B19-susceptible or -infected pediatric recipients in a genotype 3-endemic area.
    Parsyan A; Addo-Yobo E; Owusu-Ofori S; Akpene H; Sarkodie F; Allain JP
    Transfusion; 2006 Sep; 46(9):1593-600. PubMed ID: 16965589
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Parvovirus B19 may have a role in the pathogenesis of juvenile idiopathic arthritis.
    Gonzalez B; Larrañaga C; León O; Díaz P; Miranda M; Barría M; Gaggero A
    J Rheumatol; 2007 Jun; 34(6):1336-40. PubMed ID: 17477467
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Population-based study on the seroprevalence of parvovirus B19 in Amsterdam.
    van Rijckevorsel GG; Sonder GJ; Schim van der Loeff MF; van den Hoek JA
    J Med Virol; 2009 Jul; 81(7):1305-9. PubMed ID: 19475607
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Seroprevalence versus Parvovirus B19 in blood donors].
    Muñoz S; Alonso MA; Fernández MJ; Muñoz JL; García-Rodríguez JA
    Enferm Infecc Microbiol Clin; 1998 Apr; 16(4):161-2. PubMed ID: 9646558
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of IgG antibodies to human parvovirus B19 in haemophilia children treated with recombinant factor (F)VIII only or with at least one plasma-derived FVIII or FIX concentrate: results from the French haemophilia cohort.
    Gaboulaud V; Parquet A; Tahiri C; Claeyssens S; Potard V; Faradji A; Peynet J; Costagliola D;
    Br J Haematol; 2002 Feb; 116(2):383-9. PubMed ID: 11841442
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Age-related immunoglobulin G seroprevalence of human parvovirus B-19 in Israeli children.
    Miron D; Horovitz Y; Luder A; Ohnona FS; Schlesinger Y
    Isr Med Assoc J; 2010 May; 12(5):277-9. PubMed ID: 20929079
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Seroprevalence of human parvovirus B19 infection in an urban population in Malaysia.
    Ooi SL; Hooi PS; Chua BH; Lam SK; Chua KB
    Med J Malaysia; 2002 Mar; 57(1):97-103. PubMed ID: 14569725
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Seroprevalence of parvovirus B19 in patients with chronic idiopathic thrombocytopenic purpura].
    Uslu H; Kiki I; Ozbek A; Erdem F; Ayyildiz A
    Mikrobiyol Bul; 2007 Oct; 41(4):597-602. PubMed ID: 18173080
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low seroprevalence of parvovirus B19 in Taiwanese children and young adults.
    Su WJ; Ni YH; Liu DP; Chiou LS; Cheng WY; Wu JS; Lu CY
    Pediatr Neonatol; 2010 Oct; 51(5):265-8. PubMed ID: 20951355
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Prevalence of anti-human parvovirus B19 IgG antibody among blood donors in Jilin province].
    Wei Q; Li Y; Wang JW; Wang H; Qu JG; Hung T
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2006 Jun; 20(2):60-2. PubMed ID: 16816866
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Parvovirus B19 infection in children with acute illness and rash.
    Pruksachatkunakorn C; Apichartpiyakul N; Kanjanaratanakorn K
    Pediatr Dermatol; 2006; 23(3):216-8. PubMed ID: 16780465
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A seroepidemiologic study of human parvovirus B19 infection in children].
    Eiros Bouza JM; Bachiller Luque MR; Ochoa Sangrador C; Ortiz de Lejarazu R
    An Esp Pediatr; 1999 Jan; 50(1):101-2. PubMed ID: 10083659
    [No Abstract]   [Full Text] [Related]  

  • 18. The seroprevalence of parvovirus B19 infection among to-be-married girls, pregnant women, and their neonates in Shiraz, Iran.
    Ziyaeyan M; Rasouli M; Alborzi A
    Jpn J Infect Dis; 2005 Apr; 58(2):95-7. PubMed ID: 15858287
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidence of parvovirus B19 infection among an unselected population of pregnant women in the Netherlands: A prospective study.
    van Gessel PH; Gaytant MA; Vossen AC; Galama JM; Ursem NT; Steegers EA; Wildschut HI
    Eur J Obstet Gynecol Reprod Biol; 2006; 128(1-2):46-9. PubMed ID: 16406220
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative evaluation of two commercial enzyme immunoassays for serodiagnosis of human parvovirus B19 infection.
    Enders M; Helbig S; Hunjet A; Pfister H; Reichhuber C; Motz M
    J Virol Methods; 2007 Dec; 146(1-2):409-13. PubMed ID: 17854916
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.